Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05415072 |
|---|---|
| Brief Title: | A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
| First Submitted : | June 8, 2022 |
| First Submitted that Met QC Criteria : | June 8, 2022 |
| First Posted : | June 10, 2022 |
| Last Update Submitted that Met QC Criteria : | April 26, 2024 |
| Last Update Posted : | April 29, 2024 |